GC Therapeutics (original) (raw)

Empowering SuperCells™. Restoring Hope.

Cell Therapy Meets Unprecedented Scalability

GC Therapeutics (GCTx) is harnessing the world’s first “plug-and-play” induced pluripotent stem cell (iPSC) cellular programming platform, TFome™ (Transcription-Factor-ome, pronounced as tee-eff-ome), to overcome the development and scaling complexities associated with cell therapy and improve patient access across a broad range of therapeutic areas.

_“The TFome_™ can produce cells better than nature and reduce healthcare burden to improve access to advanced cell therapies.”

-George Church, Ph.D.

Co-Founder & Scientific Advisor

TFome™ (Transcription-Factor-ome) leverages the latest advancements in synthetic biology, gene editing, cell engineering and machine learning, and is designed to revolutionize cell therapy by delivering off-the-shelf iPSC-based medicines at a pace up to 100 times more rapidly than conventional methods via a single-step process with improved potency, efficiency, quality and cost.

We are advancing a pipeline of potential best-in-class cell therapy programs focused on gastrointestinal,neurologicalandimmunological diseases to make a significant impact for patients.

We are led by a passionate group of biologists and cell therapy engineers backed by a world-class team of thought leaders in the biopharma industry. Together, we aim to create a revolutionary class of new ‘SuperCell™’ medicines.

Join Us

Join our exceptional team to scale and unleash the next generation of cell therapy-based medicines.